Guidelines and Resources for the Depression Nurse Specialist
The Depression Nurse Specialist (DNS) plays a key role in initially assessing symptoms of depression, educating and activating patients, providing feedback on patients’ progress to their primary care clinician, helping to implement treatment plans, and monitoring patients to improve their compliance with their treatment regimen. This manual contains all the information required for the DNS to perform these functions. It provides an overview of the DNS’s role, including those responsibilities that are particular to patients receiving either medication or psychotherapy treatment. A series of flowcharts shows the sequence of the nurse’s activities, beginning with the first meeting with the patient and including all follow-up activities. Explicit protocols provide guidance for the nurse in dealing with patients at various stages and in specific situations, including the initial visit and evaluation, follow-up contacts, health status assessments, and activities to prevent relapses. The manual also provides all of the forms that the nurse will require while performing these responsibilities.
Download eBook for Free
|PDF file||8.1 MB||
Use Adobe Acrobat Reader version 7.0 or higher for the best experience.
- Copyright: RAND Corporation
- Availability: Available
- Print Format: Paperback
- Paperback Pages: 118
- List Price: $30.00
- Paperback Price: $24.00
- Paperback ISBN/EAN: 0-8330-2832-4
- Document Number: MR-1198/2-AHRQ
- Year: 2000
- Series: Monograph Reports
Overview of the Role of the Depression Nurse Specialist
Initial Telephone Call to Study Patients
The Initial Visit and Post-Initial Visit Plan
Assuring Privacy and Confidentiality of Patient Information
Logging and Tracking Patients
Protocols for Follow-up Visits
Maintenance Phase Treatment and Relapse Prevention
Step-by-step Guide for DNS Initial Visit Assessment
DNS Initial Assessment Queries
SF-12 Health Survey
Training Role Plays for Initial Assessment and Follow-up
Course of Action for Relapse Prevention
Commonly Asked Questions Regarding Antidepressants
This project was funded by the Agency for Healthcare Research and Quality (AHRQ), formerly the Agency for Health Care Policy and Research (AHCPR) and was conducted by RAND Health.
This report is part of the RAND Corporation monograph report series. The monograph/report was a product of the RAND Corporation from 1993 to 2003. RAND monograph/reports presented major research findings that addressed the challenges facing the public and private sectors. They included executive summaries, technical documentation, and synthesis pieces.
Permission is given to duplicate this electronic document for personal use only, as long as it is unaltered and complete. Copies may not be duplicated for commercial purposes. Unauthorized posting of RAND PDFs to a non-RAND Web site is prohibited. RAND PDFs are protected under copyright law. For information on reprint and linking permissions, please visit the RAND Permissions page.
The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.